NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 213 filers reported holding NEVRO CORP in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $424 | -79.9% | 16,689 | -71.4% | 0.00% | -82.4% |
| Q1 2023 | $2,109 | +6.0% | 58,340 | +16.2% | 0.02% | -41.4% |
| Q4 2022 | $1,989 | -99.9% | 50,217 | -6.9% | 0.03% | -12.1% |
| Q3 2022 | $2,515,000 | +3.4% | 53,963 | -2.8% | 0.03% | +10.0% |
| Q2 2022 | $2,432,000 | +170.2% | 55,494 | +399.7% | 0.03% | +233.3% |
| Q4 2021 | $900,000 | +270.4% | 11,106 | +432.4% | 0.01% | +200.0% |
| Q3 2021 | $243,000 | -83.2% | 2,086 | -79.8% | 0.00% | -85.7% |
| Q1 2021 | $1,443,000 | – | 10,343 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |